Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

erlotinib hydrochloride has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)		Trials
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)		Recent Studies (post-2010) (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
4,3537863,0331,92811,354

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Çoşut, B; Doğan, HA; Eçik, ET; Gül, EY; Karataş, EA; Karataş, ÖF1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

ArticleYear
Erlotinib-Modified BODIPY Photosensitizers for Targeted Photodynamic Therapy.
    ChemMedChem, 2023, 01-17, Volume: 18, Issue:2

    Topics: Erlotinib Hydrochloride; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species

2023